Abvc Biopharma, Inc. financial data

Symbol
ABVC on Nasdaq
Industry
Pharmaceutical Preparations
Location
44370 Old Warm Springs Blvd., Fremont, CA
State of incorporation
Nevada
Fiscal year end
December 31
Former names
American BriVision (Holding) Corp (to 4/8/2021), METU BRANDS, INC. (to 1/8/2016), Ecology Coatings, Inc. (to 9/2/2015), ECOLOGY COATINGS, INC. (to 9/2/2015), OCIS CORP (to 6/13/2007)
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 33.2 % -41.4%
Quick Ratio 0.61 %
Debt-to-equity 82.4 % -71.5%
Return On Equity -208 % +15.9%
Return On Assets -92 % +16.3%
Operating Margin -6.26K % -338%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 12.4M shares +214%
Common Stock, Shares, Outstanding 12.1M shares +264%
Entity Public Float 5.2M USD -72.4%
Common Stock, Value, Issued 12.1K USD +264%
Weighted Average Number of Shares Outstanding, Basic 11.3M shares +242%
Weighted Average Number of Shares Outstanding, Diluted 11.3M shares +242%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 136K USD -82.2%
Cost of Revenue 169K USD -58.6%
Research and Development Expense 323K USD -87.8%
Operating Income (Loss) -8.54M USD +22%
Nonoperating Income (Expense) -407K USD -925%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -11.9M USD -3.91%
Income Tax Expense (Benefit) -111K USD -236%
Net Income (Loss) Attributable to Parent -12.6M USD -3.05%
Earnings Per Share, Basic -1.69 USD/shares +70%
Earnings Per Share, Diluted -1.69 USD/shares +70%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 124K USD +25.2%
Accounts Receivable, after Allowance for Credit Loss, Current 1.53K USD -87.6%
Inventory, Net 20.5K USD -65.9%
Assets, Current 2.19M USD +2.85%
Deferred Income Tax Assets, Net 34.3K USD -96.6%
Property, Plant and Equipment, Net 7.93M USD +1305%
Operating Lease, Right-of-Use Asset 607K USD -39.3%
Assets 14.6M USD +57%
Accounts Payable, Current 2.09K USD -58.7%
Employee-related Liabilities, Current 1.24M USD
Accrued Liabilities, Current 3.7M USD +27%
Contract with Customer, Liability, Current 79.5K USD
Liabilities, Current 6.55M USD +13.4%
Operating Lease, Liability, Noncurrent 229K USD -62.4%
Liabilities 6.81M USD -29.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax 436K USD
Retained Earnings (Accumulated Deficit) -70.4M USD -19.3%
Stockholders' Equity Attributable to Parent 8.29M USD
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 7.83M USD
Liabilities and Equity 14.6M USD +57%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -473K USD +68.4%
Net Cash Provided by (Used in) Financing Activities 676K USD -69.4%
Net Cash Provided by (Used in) Investing Activities -93.2K USD +66.9%
Common Stock, Shares Authorized 100M shares +900%
Common Stock, Shares, Issued 12.1M shares +264%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -57.8K USD -114%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 743K USD +0.08%
Interest Paid, Excluding Capitalized Interest, Operating Activities 5.7K USD -89.9%
Deferred Tax Assets, Valuation Allowance 6.24M USD -1.63%
Deferred Tax Assets, Gross 6.24M USD
Operating Lease, Liability 607K USD +184%
Depreciation 13.3K USD +90.2%
Payments to Acquire Property, Plant, and Equipment 93.2K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -11.5M USD +7.67%
Lessee, Operating Lease, Liability, to be Paid 609K USD -39.5%
Property, Plant and Equipment, Gross 11.3M USD +190%
Operating Lease, Liability, Current 378K USD -3.15%
Lessee, Operating Lease, Liability, to be Paid, Year Two 56.9K USD -85.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 351K USD +80.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.01 pure 0%
Deferred Income Tax Expense (Benefit) -86.9K USD -70.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.9K USD -69.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 56.9K USD
Current Income Tax Expense (Benefit) 800 USD
Preferred Stock, Shares Authorized 20M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 56.9K USD
Additional Paid in Capital 87.1M USD +27.9%
Current State and Local Tax Expense (Benefit) 800 USD
Depreciation, Depletion and Amortization 27.4K USD +15.4%
Share-based Payment Arrangement, Expense 0 USD
Interest Expense 3.12M USD +839%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%